secwatch.observer — SEC 8-K summary
======================================

Issuer:     CDT Equity Inc. (CDT)
CIK:        0001896212
Form:       8-K
Filed at:   2024-05-31T23:59:59+00:00
Accession:  0001493152-24-022228
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Conduit Pharma gets Nasdaq deficiency notice after audit committee director resigns
--------------------------------------------------------------------------------

- Nasdaq notified Conduit on May 28, 2024 that audit committee now has only two independent directors.
- Non-compliance triggered by resignation of director Jennifer McNealey from Board and committees.
- Cure period runs until earlier of next annual meeting or May 13, 2025; no immediate delisting.
- Company intends to regain compliance by adding a third independent audit committee member.
- Common stock (CDT) and warrants (CDTTW) continue trading on Nasdaq during cure period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1896212/000149315224022228/0001493152-24-022228-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1896212/000149315224022228/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-022228

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer